MedTrace Logo

Biological Bone Markers and Hydrolyzed Collagen Supplement in Menopausal Healthy Women

NCT01293045 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2014-04-09

No results posted yet for this study

Summary

* Preliminary scientific studies, in both animals and humans suggest that oral consumption of hydrolyzed collagen acts on the bone remodeling process by stimulating the activity of osteoblasts responsible for bone formation while improving the bone mineral density and biomechanical resistance of long bones.
* The objective of this clinical research is to measure changes in biomarkers of bone turnover in postmenopausal healthy women, not osteoporotic, in response to consumption of hydrolyzed collagen for three months.
* For this, we propose to measure blood and urinary markers of formation and bone resorption before consumption, then 45 and 90 days after daily consumption of 10 g of hydrolyzed collagen.

Conditions

Interventions

DIETARY_SUPPLEMENT

hydrolyzed collagen

10g/day at breakfast during 90 days

DIETARY_SUPPLEMENT

wheat protein

10g/day at breakfast during 90 days

Sponsors & Collaborators

  • ROUSSELOT SAS

    collaborator UNKNOWN

  • Nealth Sarl

    lead NETWORK

Principal Investigators

  • Robert BENAMOUZIG, MD, PhD · Centre de Recherche en Nutrition Humaine d'Ile-de-France

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01293045 on ClinicalTrials.gov